Last reviewed · How we verify
Cysview Kit (5-aminolevulinic acid hexyl ester)
Cysview Kit (generic name: 5-aminolevulinic acid hexyl ester) is a drug developed by Photocure Asa. It is currently FDA-approved (first approved 2010).
At a glance
| Generic name | 5-aminolevulinic acid hexyl ester |
|---|---|
| Sponsor | Photocure Asa |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
| First approval | 2010 |
Approved indications
Common side effects
Key clinical trials
- Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) (PHASE4)
- Blue Light Cystoscopy With Cysview® Registry
- Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection (PHASE3)
- Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer (PHASE3)
- The Impact of PDD During TURB for NMIBC (PHASE4)
- Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT (PHASE2,PHASE3)
- Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection (NA)
- The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic Diagnostics (PHASE2)
Patents
| Patent | Expiry | Type |
|---|---|---|
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| FDA Orange Book | Patents + exclusivity |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cysview Kit CI brief — competitive landscape report
- Cysview Kit updates RSS · CI watch RSS
- Photocure Asa portfolio CI
Frequently asked questions about Cysview Kit
What is Cysview Kit?
Cysview Kit (5-aminolevulinic acid hexyl ester) is a pharmaceutical drug developed by Photocure Asa.
Who makes Cysview Kit?
Cysview Kit is developed and marketed by Photocure Asa (see full Photocure Asa pipeline at /company/photocure-asa).
What is the generic name of Cysview Kit?
5-aminolevulinic acid hexyl ester is the generic (nonproprietary) name of Cysview Kit.
When was Cysview Kit approved?
Cysview Kit was first approved on 2010.
What development phase is Cysview Kit in?
Cysview Kit is FDA-approved (marketed).
Related
- Manufacturer: Photocure Asa — full pipeline
- Therapeutic area: All drugs in Oncology
- Compare: Cysview Kit vs similar drugs
- Pricing: Cysview Kit cost, discount & access